9.790
−0,20%
2026-10-19
Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -46.9% | -61.6% | 0 / 3 | +20.2% | -20.19 pp | -14.19 pp | +4.2% | 0.00 | 12.69 | 179 | +20,2% | 20,2 | −46,9% | 12.69 | 11.14 | +13,9% |
| Pts | 0 | 0 | 0 | 12 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 9.790 (close price on 2026-10-19)EPS (TTM): 771,6
Financial charts
1.Revenue & growth
VND bn179Q2/26
1.Revenue & growth
VND bn179Q2/26
2.Profit & growth
VND bn20,2Q2/26
3.Profit mix (Penman)
VND bn68,6Q2/26
4.Margins & cost structure
%18.7%Q2/26
5.Returns & cash cycle
% · days6.3%Q2/26
6.Earnings quality & cash
VND bn44,6Q2/26
7.Asset structure
VND bn1.445Q2/26
8.Funding & debt health
VND bn · times1.445Q2/26
9.Revenue backlog
VND bn12,5Q2/26
10.Valuation
times · %12,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %295Q2/26
Adjusted EPS growth, latest quarter
-46.9%
Average adjusted EPS growth, 3 quarters
-61.6%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26